Vitreous Fluid Levels of ?-Amyloid(1?2) and Tau in Patients with Retinal Diseases
详细信息    查看全文
文摘
Purpose A decrease in -amyloid1–42 (A42) and an increase in tau in the cerebrospinal fluid are reported to be characteristic phenomena in Alzheimers disease patients. To test the idea that A42 and tau contribute to the development of retinal diseases, we measured A42 and tau concentrations in the vitreous fluid from patients with macular hole (n = 13), diabetic retinopathy (n = 15), or glaucoma concurrent with other ocular diseases (n = 8).

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700